Anti-obesity drug fragment
Also known as Anti-obesity drug fragment — this name points to AOD-9604 in our directory.
Also known as Anti-obesity drug fragment — this name points to AOD-9604 in our directory.
A fragment of human growth hormone studied for fat loss without IGF-1 effects.
AOD-9604 is the C-terminal fragment of hGH (amino acids 176–191). Trials explored fat reduction without growth effects; results were modest. WADA-prohibited. Sold as a research peptide for body recomposition—evidence is weak.
Anti-obesity drug fragment is a marketing or trade name people search when they mean AOD-9604. On retail shelves the INCI list on the back of the package may use a longer systematic name even when the front label shows a nickname.
Yes. Anti-obesity drug fragment is a brand or nickname that refers to AOD-9604 in our directory—the same active molecule, different packaging or marketing name.
A fragment of human growth hormone studied for fat loss without IGF-1 effects. AOD-9604 is the C-terminal fragment of hGH (amino acids 176–191). Trials explored fat reduction without growth effects; results were modest. WADA-prohibited. Sold as a research peptide for body recomposition—evidence is weak.
Anti-obesity drug fragment may appear on retail product fronts, but confirm the INCI list matches AOD-9604 before assuming the formula is identical across brands.